We are live on ! Find out more
VRX

VALEANT PHARMACEUTICALS INTL
VRX

Delisted

VRX was delisted on the 27th of September, 2010.

Back to rankings

1 hedge funds and large institutions have $871 invested in VALEANT PHARMACEUTICALS INTL in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

41% less capital invested

Capital invested by funds: $1.47K → $871 (-$602)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
1
Sonora Investment Management
Arizona
$871 – – –

VRX Hedge Fund Activity: Q4 2016 in Review

1 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q4 2016, worth a combined $871 — down 41% from $1.47K a quarter earlier.

Fund positioning in VRX was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held VALEANT PHARMACEUTICALS INTL (VRX) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $871 of VALEANT PHARMACEUTICALS INTL stock for Q4 2016, down 41% quarter-over-quarter.
  • 0 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q4 2016 and 0 closed out.

Based on aggregated 13F filings for Q4 2016.